Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Pembroke Pines, FL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Ponte Vedra, FL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Ponte Vedra, FL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Tampa, FL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Atlanta, GA
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Canton, GA
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Canton, GA
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Idaho Falls, ID
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Meridian, ID
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Meridian, ID
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Chicago, IL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Chicago, IL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Chicago, IL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Evansville, IL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Evansville, IL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Avon, IN
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Avon, IN
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Evansville, IN
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Evansville, IN
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Franklin, IN
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Franklin, IN
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Greenfield, IN
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Greenfield, IN
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Muncie, IN
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Muncie, IN
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Valparaiso, IN
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Valparaiso, IN
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Des Moines, IA
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Des Moines, IA
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Des Moines, IA
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Des Moines, IA
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Newton, KA
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Newton, KA
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Metaire, LA
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Metaire, LA
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Metairie, LA
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Metairie, LA
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Metarie, LA
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Metarie, LA
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
New Orleans, LA
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
New Orleans, LA
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Baltimore, MD
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Brockton, MA
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Brockton, MA
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Rochester, MI
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Rochester, MI
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Ypsilanti, MI
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Kansas City, MO
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Billings, MT
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Billings, MT
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Lincoln, NE
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Lincoln, NE
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Las Vegas, NV
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Toms River, NJ
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Toms River, NJ
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Brooklyn, NY
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Brooklyn, NY
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Endwell, NY
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Endwell, NY
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Staten Island, NY
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Staten Island, NY
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Charlotte, NC
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Charlotte, NC
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Durham, NC
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Greensboro, NC
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Greensboro, NC
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Hickory, NC
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Hickory, NC
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Moorehead City, NC
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Moorehead City, NC
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Moorehead City, NC
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Moorehead City, NC
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Mooresville, NC
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Mooresville, NC
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Mooresville, NC
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Mooresville, NC
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Salisbury, NC
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Salisbury, NC
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Wilmington, NC
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Wilmington, NC
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Winston-Salem, NC
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Winston-Salem, NC
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Cincinnati, OH
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials